- Udyam number
- UDYAM-KL-02-0016285
About TCM Limited
Data last updated:
TCM Limited is a public limited company based in Kochi, Kerala, India. It operates in the animal feeds segment of the agriculture sector. It was incorporated on 20 April 1943 and has been in existence for over 83 years.
The company is registered with the Registrar of Companies (ROC), Ernakulam, under CIN L24299KL1943PLC001192. Its GSTIN is 32AAACT6206A1Z4 (Kerala). The company holds 4 GST registrations, of which 2 are active. Its shares are listed on BSE: 524156.
The company has an authorised share capital of ₹10 Cr and a paid-up capital of ₹7.48 Cr. It was formerly known as The Travancore Chemical & Manufacturing Company Limited. It is led by directors including Joseph Varghese (Managing Director) and Rani Jose.
Its last annual general meeting (AGM) was held on 27 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Kochi, Kerala.
As per the latest consolidated financials for FY 2025-26, the company reported a revenue of ₹19.74 Cr, a decline of 24.1% compared to the previous year. For the same year it recorded a net loss of ₹5.8 Cr (net margin -29.4%) and EBITDA of -₹4.38 Cr (EBITDA margin -22.2%). The net worth stands at ₹24.7 Cr (down 19.1% YoY). Total assets are valued at ₹46.18 Cr (up 13.6% YoY).
Its group structure includes 1 subsidiary.
The company is associated with 1 brand: TCM Limited. As per MCA filings, the company has open charges of ₹24.68 Cr and satisfied charges of ₹39.86 Cr on record. Court records list 70 cases involving the company, including 33 filed by the company and 24 filed against it; 7 cases are pending. The company has 18 deals on record (17 market trades, 1 rights issue); the latest was in May 2026. Its 10 peer companies in the Agriculture industry (Animal Feeds, Healthcare Equipment Retail and Distribution, Industrial Chemicals) are compared by revenue, 5 larger and 5 smaller; the largest is Asomiya Mahila Poultry Producer Company Limited with revenue of ₹30.74 Cr.
TCM Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-KL-02-0016285). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website tcmlimited.in.
Recognitions & Rankings of TCM
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressHouse No.28/2917 (Ground Floor) 'Aiswarya' Shanthi Nagar Ponneth Temple Road Kada, Vanthra, Kochi, Kerala, India – 682020
- IndustryAgriculture, Animal Feeds
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Associated Brands with TCM Limited
TCM operates one associated brand: TCM Limited. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| TCM Limited is engaged in renewable energy, healthcare, and trading. | tcmlimited.in |
Business Activity of TCM Limited
The main business activity of TCM is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and other manufacturing including jewellery, musical instruments, medical instruments, sports goods, etc. activities. 2 activity segments are registered with the MCA.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
| C | Manufacturing | C13 | Other manufacturing including jewellery, musical instruments, medical instruments, sports goods, etc. activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of TCM Limited FY 2025-26 filings available
TCM Limited reported revenue of ₹19.74 Cr (down 24.1% YoY) for FY 2025-26.
Financial Highlights
FY 2025-26 · ConsolidatedRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 19.74 | 26.01 | 32.23 | 7.35 | 3.55 | 4.25 | 0.92 |
| Revenue growth | -24.1% | -19.3% | +338.5% | +107.0% | -16.5% | +362.0% | - |
| EBITDA | (4.38) | (2.15) | (2.23) | (3.66) | (6.58) | (0.89) | (0.83) |
| EBITDA margin | -22.2% | -8.3% | -6.9% | -49.8% | -185.4% | -20.9% | -90.2% |
| Profit before tax | (6.02) | 1.36 | (2.26) | (4.29) | (5.87) | 0.30 | 0.30 |
| Net profit | (5.80) | 1.78 | (1.96) | (3.99) | (2.92) | (0.07) | 0.30 |
| Net profit margin | -29.4% | +6.8% | -6.1% | -54.3% | -82.3% | -1.7% | +32.6% |
| EPS (₹) | (7.77) | 2.16 | (2.61) | (5.35) | (15.11) | 0.35 | 0.89 |
| Balance sheet | |||||||
| Total assets | 46.18 | 40.65 | 47.69 | 51.12 | 50.43 | 58.10 | 57.80 |
| Net worth | 24.70 | 30.52 | 28.79 | 30.74 | 25.33 | 32.59 | 32.47 |
| Total debt | 22.16 | 11.22 | 0.27 | 1.44 | 6.53 | 5.83 | 5.64 |
| Cash & bank | 0.78 | 0.41 | 0.54 | 0.21 | 0.28 | 0.07 | 0.02 |
| Net working capital | 7.51 | 6.28 | 9.38 | (8.23) | (6.44) | (3.58) | (2.55) |
| Cash flow | |||||||
| Cash from operations | (5.22) | (10.08) | 1.95 | (10.87) | (4.21) | 0.39 | (0.57) |
| Cash from investing | (3.59) | (0.18) | (0.64) | 5.84 | 4.22 | (0.51) | 0.00 |
| Cash from financing | 9.02 | 10.37 | (1.30) | 4.87 | 0.19 | 0.18 | (3.14) |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 4.88 | 4.92 | 5.69 | 5.92 | 3.21 | 7.65 | 6.18 | 6.90 |
| Revenue growth (YoY) | +52.0% | -35.7% | -7.9% | -14.2% | -39.2% | - | - | - |
| Other income | 0.06 | 0.21 | 0.09 | 0.60 | 0.06 | 4.34 | 0.06 | 0.03 |
| EBITDA | (0.98) | (1.17) | (0.55) | (0.83) | (1.96) | 0.05 | (0.59) | (0.58) |
| EBITDA margin | -20.1% | -23.8% | -9.7% | -14.0% | -61.1% | +0.7% | -9.5% | -8.4% |
| Depreciation | 0.16 | 0.18 | 0.17 | 0.11 | 0.10 | 0.10 | 0.09 | 0.08 |
| Interest | 0.52 | 0.50 | 0.54 | 0.50 | 0.39 | 0.31 | 0.28 | 0.00 |
| Profit before tax | (1.60) | (1.64) | (1.17) | (0.84) | (2.39) | 3.98 | (0.90) | (0.63) |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | (0.04) | (0.03) | 0.00 | 0.00 |
| Net profit | (1.60) | (1.64) | (1.17) | (0.84) | (2.35) | 4.01 | (0.90) | (0.63) |
| EPS (₹) | (21.40) | (2.20) | (1.53) | (1.05) | (3.00) | 5.39 | (1.16) | (0.77) |
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 17.23 | 24.73 | 31.65 | 7.16 | 3.46 | 4.25 | 0.92 |
| Revenue growth | -30.3% | -21.9% | +342.0% | +106.9% | -18.6% | +362.0% | - |
| EBITDA | (2.58) | (0.90) | (0.33) | (2.54) | (4.89) | (0.04) | (0.74) |
| EBITDA margin | -15.0% | -3.6% | -1.0% | -35.5% | -141.3% | -0.9% | -80.4% |
| Profit before tax | (3.67) | 3.12 | 0.27 | (2.77) | (3.92) | 1.16 | 0.39 |
| Net profit | (3.63) | 3.33 | 0.23 | (2.75) | (1.71) | 0.66 | 0.39 |
| Net profit margin | -21.1% | +13.5% | +0.7% | -38.4% | -49.4% | +15.5% | +42.4% |
| EPS (₹) | (4.85) | 4.21 | 0.27 | (3.70) | (11.55) | 2.89 | 1.14 |
| Balance sheet | |||||||
| Total assets | 57.18 | 49.29 | 54.57 | 55.16 | 52.84 | 59.04 | 57.87 |
| Net worth | 34.21 | 37.84 | 34.58 | 34.38 | 27.13 | 33.54 | 32.56 |
| Total debt | 22.16 | 11.22 | 0.27 | 1.08 | 6.02 | 5.83 | 5.64 |
| Cash & bank | 0.67 | 0.38 | 0.52 | 0.18 | 0.27 | 0.05 | 0.02 |
| Net working capital | 10.18 | 7.90 | 9.14 | (8.10) | (6.12) | (3.55) | (2.42) |
| Cash flow | |||||||
| Cash from operations | (4.50) | (10.79) | 3.74 | (9.56) | (2.79) | (0.11) | (0.56) |
| Cash from investing | (4.40) | 0.53 | (2.78) | 4.39 | 2.81 | (0.04) | (0.01) |
| Cash from financing | 9.02 | 10.37 | (0.94) | 4.99 | 0.20 | 0.18 | (3.14) |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 4.02 | 3.97 | 5.20 | 5.02 | 3.05 | 7.28 | 5.89 | 6.49 |
| Revenue growth (YoY) | +31.8% | -45.5% | -11.7% | -22.7% | -39.8% | - | - | - |
| Other income | 0.17 | 0.29 | 0.18 | 0.67 | 0.16 | 4.38 | 0.12 | 0.13 |
| Total expenses | 4.77 | 4.92 | 5.28 | 5.44 | 4.29 | 6.99 | 6.23 | 6.79 |
| EBITDA | (0.75) | (0.95) | (0.08) | (0.42) | (1.24) | 0.29 | (0.34) | (0.30) |
| EBITDA margin | -18.7% | -23.9% | -1.5% | -8.4% | -40.7% | +4.0% | -5.8% | -4.6% |
| Depreciation | 0.12 | 0.12 | 0.12 | 0.06 | 0.06 | 0.09 | 0.03 | 0.02 |
| Interest | 0.52 | 0.49 | 0.54 | 0.50 | 0.38 | 0.31 | 0.28 | 0.00 |
| Profit before tax | (1.22) | (1.27) | (0.56) | (0.31) | (1.52) | 4.27 | (0.53) | (0.19) |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | (0.04) | (0.03) | 0.00 | 0.00 |
Financial Statements
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 4.88 | 4.92 | 5.69 | 5.92 | 3.21 | 7.65 | 6.18 | 6.90 |
| Revenue growth (YoY) | +52.0% | -35.7% | -7.9% | -14.2% | -39.2% | - | - | - |
| Other income | 0.06 | 0.21 | 0.09 | 0.60 | 0.06 | 4.34 | 0.06 | 0.03 |
| EBITDA | (0.98) | (1.17) | (0.55) | (0.83) | (1.96) | 0.05 | (0.59) | (0.58) |
| EBITDA margin | -20.1% | -23.8% | -9.7% | -14.0% | -61.1% | +0.7% | -9.5% | -8.4% |
| Depreciation | 0.16 | 0.18 | 0.17 | 0.11 | 0.10 | 0.10 | 0.09 | 0.08 |
| Interest | 0.52 | 0.50 | 0.54 | 0.50 | 0.39 | 0.31 | 0.28 | 0.00 |
| Profit before tax | (1.60) | (1.64) | (1.17) | (0.84) | (2.39) | 3.98 | (0.90) | (0.63) |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | (0.04) | (0.03) | 0.00 | 0.00 |
| Net profit | (1.60) | (1.64) | (1.17) | (0.84) | (2.35) | 4.01 | (0.90) | (0.63) |
| EPS (₹) | (21.40) | (2.20) | (1.53) | (1.05) | (3.00) | 5.39 | (1.16) | (0.77) |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 19.74 | 26.01 | 32.23 | 7.35 | 3.55 | 4.25 | 0.92 |
| Revenue growth | -24.1% | -19.3% | +338.5% | +107.0% | -16.5% | +362.0% | - |
| Other income | 0.96 | 4.47 | 0.43 | 0.02 | 0.89 | 1.23 | 1.15 |
| Total expenses | 24.12 | 28.16 | 34.46 | 11.01 | 10.13 | 5.14 | 1.75 |
| Employee cost | 4.87 | 3.81 | 3.71 | 1.88 | 1.99 | 1.07 | 0.34 |
| EBITDA | (4.38) | (2.15) | (2.23) | (3.66) | (6.58) | (0.89) | (0.83) |
| EBITDA margin | -22.2% | -8.3% | -6.9% | -49.8% | -185.4% | -20.9% | -90.2% |
| Depreciation | 0.56 | 0.35 | 0.30 | 0.37 | 0.17 | 0.03 | 0.01 |
| Interest | 2.04 | 0.61 | 0.16 | 0.28 | 0.01 | 0.01 | 0.01 |
| Profit before tax | (6.02) | 1.36 | (2.26) | (4.29) | (5.87) | 0.30 | 0.30 |
| Tax | (0.04) | (0.03) | 0.04 | (0.03) | 0.00 | 0.19 | 0.00 |
| Net profit | (5.80) | 1.78 | (1.96) | (3.99) | (2.92) | (0.07) | 0.30 |
| Net profit margin | -29.4% | +6.8% | -6.1% | -54.3% | -82.3% | -1.7% | +32.6% |
| EPS (₹) | (7.77) | 2.16 | (2.61) | (5.35) | (15.11) | 0.35 | 0.89 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 7.48 | 7.48 | 7.48 | 7.48 | 3.40 | 3.40 | 3.40 |
| Reserves & surplus | 17.22 | 23.04 | 21.31 | 23.26 | 21.93 | 29.19 | 29.07 |
| Shareholders' funds (net worth) | 24.70 | 30.52 | 28.79 | 30.74 | 25.33 | 32.59 | 32.47 |
| Minority interest | (1.49) | (1.31) | (1.10) | (0.76) | (1.11) | 0.00 | 0.00 |
| Secured loans | 19.85 | 11.09 | 0.14 | 0.08 | 0.09 | 0.00 | 0.00 |
| Unsecured loans | 2.31 | 0.13 | 0.13 | 1.36 | 6.44 | 5.83 | 5.64 |
| Total debt | 22.16 | 11.22 | 0.27 | 1.44 | 6.53 | 5.83 | 5.64 |
| Total liabilities | 46.18 | 40.65 | 47.69 | 51.12 | 50.43 | 58.10 | 57.80 |
| Assets | |||||||
| Gross block | 18.03 | 15.33 | 18.17 | 36.30 | 55.50 | 58.87 | 58.03 |
| Net block | 16.30 | 14.09 | 17.28 | 35.71 | 55.28 | 58.82 | 58.01 |
| Capital work in progress | 0.35 | 0.10 | 0.10 | 0.10 | 0.02 | 0.06 | 0.00 |
| Investments | 0.30 | 0.30 | 0.00 | 0.00 | 0.00 | 0.18 | 0.19 |
| Inventories | 26.73 | 28.44 | 30.58 | 3.79 | 1.37 | 2.41 | 1.51 |
| Sundry debtors | 6.24 | 6.77 | 8.51 | 4.69 | 1.90 | 2.52 | 1.78 |
| Cash & bank balances | 0.78 | 0.41 | 0.54 | 0.21 | 0.28 | 0.07 | 0.02 |
| Loans & advances | 10.10 | 6.41 | 5.85 | 0.77 | 1.01 | 1.05 | 1.77 |
| Total current assets | 43.85 | 42.03 | 45.48 | 9.46 | 4.56 | 6.05 | 5.08 |
| Total current liabilities | 36.34 | 35.75 | 36.10 | 17.69 | 11.00 | 9.63 | 7.63 |
| Net working capital | 7.51 | 6.28 | 9.38 | (8.23) | (6.44) | (3.58) | (2.55) |
| Total assets | 46.18 | 40.65 | 47.69 | 51.12 | 50.43 | 58.10 | 57.80 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 0.23 | 0.12 | 0.12 | 0.28 | 0.07 | 0.02 | 3.72 |
| Net cash from operating activities | (5.22) | (10.08) | 1.95 | (10.87) | (4.21) | 0.39 | (0.57) |
| Net cash from investing activities | (3.59) | (0.18) | (0.64) | 5.84 | 4.22 | (0.51) | 0.00 |
| Net cash from financing activities | 9.02 | 10.37 | (1.30) | 4.87 | 0.19 | 0.18 | (3.14) |
| Net change in cash | 0.21 | 0.11 | 0.00 | (0.15) | 0.20 | 0.06 | (3.70) |
| Closing cash | 0.78 | 0.41 | 0.54 | 0.21 | 0.28 | 0.07 | 0.02 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | -24.1% | -19.3% | +338.5% | +107.0% | -16.5% | +362.0% | - |
| EBITDA growth | -103.7% | +3.6% | +39.1% | +44.4% | -639.3% | -7.2% | - |
| PBT growth | - | +9998.0% | +47.3% | +26.9% | - | 0.0% | +9998.0% |
| Net income growth | -425.8% | +190.8% | +50.9% | -36.6% | -4071.4% | -123.3% | - |
| Revenue CAGR (3Y) | +39.0% | +94.2% | +96.5% | +99.9% | +107.0% | - | - |
| EBITDA CAGR (3Y) | +6.2% | -31.1% | +35.8% | +64.0% | +96.3% | - | - |
| Profitability & leverage | |||||||
| Net income margin | -30.3% | +5.3% | -7.1% | -58.0% | -165.4% | +2.6% | +32.6% |
| Return on capital employed | -8.9% | +4.8% | -4.2% | -7.8% | -5.2% | -0.1% | +0.5% |
| Return on net worth | -21.7% | +5.3% | -7.7% | -15.2% | -8.1% | -0.1% | +0.9% |
| Debt / equity | 0.60 | 0.19 | 0.03 | 0.14 | 0.21 | 0.18 | 0.17 |
| Long-term debt / equity | 0.16 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest cover | -41.30 | -24.40 | -6.32 | -6.95 | -0.15 | -1.09 | -1.19 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 1.18 | 1.55 | 1.18 | 0.16 | 0.06 | 0.07 | 0.02 |
| Inventory turnover | 0.72 | 0.88 | 1.88 | 2.85 | 1.88 | 2.17 | 0.57 |
| Debtors turnover | 3.03 | 3.40 | 4.88 | 2.23 | 1.61 | 1.98 | 0.56 |
| EPS (₹) | (7.77) | 2.16 | (2.61) | (5.35) | (15.11) | 0.35 | 0.89 |
| Dividend per share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (₹) | 33.03 | 40.81 | 38.50 | 41.11 | 74.51 | 95.76 | 95.41 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 4.02 | 3.97 | 5.20 | 5.02 | 3.05 | 7.28 | 5.89 | 6.49 |
| Revenue growth (YoY) | +31.8% | -45.5% | -11.7% | -22.7% | -39.8% | - | - | - |
| Other income | 0.17 | 0.29 | 0.18 | 0.67 | 0.16 | 4.38 | 0.12 | 0.13 |
| Total expenses | 4.77 | 4.92 | 5.28 | 5.44 | 4.29 | 6.99 | 6.23 | 6.79 |
| EBITDA | (0.75) | (0.95) | (0.08) | (0.42) | (1.24) | 0.29 | (0.34) | (0.30) |
| EBITDA margin | -18.7% | -23.9% | -1.5% | -8.4% | -40.7% | +4.0% | -5.8% | -4.6% |
| Depreciation | 0.12 | 0.12 | 0.12 | 0.06 | 0.06 | 0.09 | 0.03 | 0.02 |
| Interest | 0.52 | 0.49 | 0.54 | 0.50 | 0.38 | 0.31 | 0.28 | 0.00 |
| Profit before tax | (1.22) | (1.27) | (0.56) | (0.31) | (1.52) | 4.27 | (0.53) | (0.19) |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | (0.04) | (0.03) | 0.00 | 0.00 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 17.23 | 24.73 | 31.65 | 7.16 | 3.46 | 4.25 | 0.92 |
| Revenue growth | -30.3% | -21.9% | +342.0% | +106.9% | -18.6% | +362.0% | - |
| Other income | 1.30 | 4.78 | 0.82 | 0.23 | 1.02 | 1.23 | 1.15 |
| Total expenses | 19.81 | 25.63 | 31.98 | 9.70 | 8.35 | 4.29 | 1.66 |
| Employee cost | 2.07 | 2.13 | 2.09 | 1.05 | 0.91 | 0.56 | 0.26 |
| EBITDA | (2.58) | (0.90) | (0.33) | (2.54) | (4.89) | (0.04) | (0.74) |
| EBITDA margin | -15.0% | -3.6% | -1.0% | -35.5% | -141.3% | -0.9% | -80.4% |
| Depreciation | 0.35 | 0.16 | 0.07 | 0.19 | 0.04 | 0.02 | 0.01 |
| Interest | 2.04 | 0.60 | 0.15 | 0.27 | 0.01 | 0.01 | 0.01 |
| Profit before tax | (3.67) | 3.12 | 0.27 | (2.77) | (3.92) | 1.16 | 0.39 |
| Tax | (0.04) | (0.03) | 0.04 | (0.02) | 0.00 | 0.18 | 0.00 |
| Net profit | (3.63) | 3.33 | 0.23 | (2.75) | (1.71) | 0.66 | 0.39 |
| Net profit margin | -21.1% | +13.5% | +0.7% | -38.4% | -49.4% | +15.5% | +42.4% |
| EPS (₹) | (4.85) | 4.21 | 0.27 | (3.70) | (11.55) | 2.89 | 1.14 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 7.48 | 7.48 | 7.48 | 7.48 | 3.40 | 3.40 | 3.40 |
| Reserves & surplus | 26.73 | 30.36 | 27.10 | 26.90 | 23.73 | 30.14 | 29.16 |
| Shareholders' funds (net worth) | 34.21 | 37.84 | 34.58 | 34.38 | 27.13 | 33.54 | 32.56 |
| Secured loans | 19.85 | 11.09 | 0.14 | 0.08 | 0.09 | 0.00 | 0.00 |
| Unsecured loans | 2.31 | 0.13 | 0.13 | 1.00 | 5.93 | 5.83 | 5.64 |
| Total debt | 22.16 | 11.22 | 0.27 | 1.08 | 6.02 | 5.83 | 5.64 |
| Total liabilities | 57.18 | 49.29 | 54.57 | 55.16 | 52.84 | 59.04 | 57.87 |
| Assets | |||||||
| Gross block | 16.56 | 14.10 | 17.19 | 35.39 | 54.77 | 58.46 | 58.03 |
| Net block | 15.77 | 13.60 | 16.85 | 35.12 | 54.69 | 58.42 | 58.01 |
| Capital work in progress | 0.25 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 2.06 | 1.62 | 0.91 | 0.52 | 0.17 | 0.19 | 0.19 |
| Inventories | 26.72 | 28.44 | 30.58 | 3.79 | 1.37 | 2.41 | 1.51 |
| Sundry debtors | 6.13 | 6.74 | 8.45 | 4.67 | 1.85 | 2.52 | 1.78 |
| Cash & bank balances | 0.67 | 0.38 | 0.52 | 0.18 | 0.27 | 0.05 | 0.02 |
| Loans & advances | 9.92 | 6.19 | 4.79 | 0.60 | 0.90 | 0.94 | 1.83 |
| Total current assets | 43.44 | 41.75 | 44.34 | 9.24 | 4.39 | 5.92 | 5.14 |
| Total current liabilities | 33.26 | 33.85 | 35.20 | 17.34 | 10.51 | 9.47 | 7.56 |
| Net working capital | 10.18 | 7.90 | 9.14 | (8.10) | (6.12) | (3.55) | (2.42) |
| Total assets | 57.18 | 49.29 | 54.57 | 55.16 | 52.84 | 59.04 | 57.87 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 0.21 | 0.10 | 0.09 | 0.27 | 0.05 | 0.02 | 3.72 |
| Net cash from operating activities | (4.50) | (10.79) | 3.74 | (9.56) | (2.79) | (0.11) | (0.56) |
| Net cash from investing activities | (4.40) | 0.53 | (2.78) | 4.39 | 2.81 | (0.04) | (0.01) |
| Net cash from financing activities | 9.02 | 10.37 | (0.94) | 4.99 | 0.20 | 0.18 | (3.14) |
| Net change in cash | 0.13 | 0.11 | 0.01 | (0.18) | 0.22 | 0.03 | (3.70) |
| Closing cash | 0.67 | 0.38 | 0.52 | 0.18 | 0.27 | 0.05 | 0.02 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | -30.3% | -21.9% | +342.0% | +106.9% | -18.6% | +362.0% | - |
| EBITDA growth | -186.7% | -172.7% | +87.0% | +48.1% | - | +94.6% | - |
| PBT growth | - | +1055.6% | +9998.0% | +29.3% | - | +197.4% | +9998.0% |
| Net income growth | -209.0% | +1347.8% | +108.4% | -60.8% | -359.1% | +69.2% | - |
| Revenue CAGR (3Y) | +34.0% | +92.6% | +95.3% | +98.2% | +105.3% | - | - |
| EBITDA CAGR (3Y) | +0.5% | -43.1% | +102.1% | +50.9% | +77.8% | -65.6% | +0.9% |
| Profitability & leverage | |||||||
| Net income margin | -21.1% | +12.7% | +0.7% | -38.4% | -113.3% | +23.1% | +42.4% |
| Return on capital employed | -3.1% | +7.2% | +0.7% | -4.7% | -2.4% | +1.1% | +0.7% |
| Return on net worth | -10.1% | +8.7% | +0.6% | -9.0% | -3.7% | +1.4% | +1.2% |
| Debt / equity | 0.46 | 0.16 | 0.02 | 0.12 | 0.20 | 0.17 | 0.17 |
| Long-term debt / equity | 0.12 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest cover | -69.62 | -56.60 | -37.50 | -9.89 | -0.20 | -16.67 | -1.33 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 1.12 | 1.58 | 1.20 | 0.16 | 0.06 | 0.07 | 0.02 |
| Inventory turnover | 0.62 | 0.84 | 1.84 | 2.78 | 1.83 | 2.17 | 0.57 |
| Debtors turnover | 2.68 | 3.26 | 4.82 | 2.20 | 1.58 | 1.98 | 0.56 |
| EPS (₹) | (4.85) | 4.21 | 0.27 | (3.70) | (11.55) | 2.89 | 1.14 |
| Dividend per share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (₹) | 45.75 | 50.61 | 46.24 | 45.97 | 79.82 | 98.67 | 95.78 |
Board of Directors of TCM Limited
TCM has 8 current directors and 11 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rani Jose | Director | 26 Mar 2015 | 11 Years 6 Months | Current |
| Joseph Varghese Also directs: Elenjikal Aqua Marine Exports Limited, TCM Healthcare Private Limited, Coastline Aviation Management Private Limited and 5 more | Managing Director | 31 Dec 2005 | 20 Years 9 Months | Current |
| Jose Jacob Also directs: Ispark Learning Solutions Private Limited | Director | 29 Sep 2021 | 5 Years 0 Months | Current |
| Gopalakrishnan Mahesh | Director | 29 Sep 2021 | 5 Years 0 Months | Current |
| George Varghese | Director | 19 Jan 2007 | 19 Years 9 Months | Current |
| Ramesh Babu | Director | 29 Sep 2022 | 4 Years 0 Months | Current |
Peer Comparison of TCM Limited
TCM Limited is compared with the companies closest to it by revenue in the Agriculture industry (Animal Feeds, Healthcare Equipment Retail and Distribution, Industrial Chemicals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Asomiya Mahila Poultry Producer Company Limited | ₹30.74 Cr (FY 2024) | •••• | •••• | 57.0% | •••• | Moran, Assam, India |
| Odisha State Medical Corporation Limited | ₹30.61 Cr (FY 2022) | •••• | •••• | 31.0% | •••• | Bhubaneswar, Odisha, India |
| Variety Vyapaar Pvt Ltd | ₹30.58 Cr (FY 2024) | •••• | •••• | 37.0% | •••• | Kolkata, West Bengal, India |
| Versatile Specialty Chemicals Limited | ₹30.55 Cr (FY 2024) | •••• | •••• | 388.0% | •••• | Dhule, Maharashtra, India |
| Gargi Chemicals Private Limited | ₹30.54 Cr (FY 2025) | •••• | •••• | 5.0% | •••• | Mumbai, Maharashtra, India |
| Calcutta Medisolutions Private Limited | ₹30.46 Cr (FY 2025) | •••• | •••• | 49.0% | •••• | Kolkata, West Bengal, India |
| Sushen Medicamentos Private Limited | ₹30.42 Cr (FY 2025) | •••• | •••• | 1.0% | •••• | Ahmedabad, Gujarat, India |
| Kashiram Juglal Exim Private Limited | ₹30.41 Cr (FY 2025) | •••• | •••• | 14.0% | •••• | Shahjahanpur, Uttar Pradesh, India |
| Kaeros Research Limited | ₹30.4 Cr (FY 2025) | •••• | •••• | 5198.0% | •••• | Delhi, India |
| Clean Solar Power (Dhar) Private Limited | ₹30.35 Cr (FY 2025) | •••• | •••• | 2.0% | •••• | New Delhi, Delhi, India |
| TCM Limited this company | ₹19.74 Cr (FY 2026) | •••• | •••• | -24.1% | •••• | Kochi, Kerala, India |
Peers are the five companies nearest above and the five nearest below TCM by revenue in the Agriculture industry (Animal Feeds, Healthcare Equipment Retail and Distribution, Industrial Chemicals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of TCM Limited
TCM Limited is audited by S G M & Associates LLP for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| S G M & Associates LLP | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Shareholding Pattern of TCM Limited
Shareholding for the quarter ended Mar 2026: promoters hold 49.50%, foreign institutional investors hold 0.00%, domestic institutional investors hold 7.40% and retail and other public shareholders hold 43.10%.
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | |
|---|---|---|---|---|
| Promoters | 49.50% | 49.50% | 49.50% | 49.50% |
| Public | 50.50% | 50.50% | 50.50% | 50.50% |
Charges & Borrowings of TCM Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Feb 2026 | Indian Bank | ₹1.37 Cr | Open |
| 31 May 2025 | Indian Bank | ₹7.43 Cr | Open |
| 16 Oct 2024 | Others | ₹11 Cr | Open |
| 16 Feb 1996 | The Industrial Finance Corporation of India Ltd | ₹1.38 Cr | Open |
| 31 Jan 1995 | The Industrial Credit and Investment Corporation of India L | ₹1.5 Cr | Open |
Total charge records: 24 View all charges
Deals & Funding of TCM Limited
TCM Limited has 18 deals on record (17 market trades, 1 rights issue); the latest was in May 2026.
Deals on record (5 of 18)
| When | Deal | Amount | Parties |
|---|---|---|---|
| May 2026 | Market trade | ₹20.1 Lakh | Buyer: an individual |
| Nov 2023 | Market trade | ₹41.1 Lakh | Buyer: Multiplier Share and Stock Advisors Private Limited Seller: Multiplier Share and Stock Advisors Private Limited |
| Nov 2023 | Market trade | ₹23 Lakh | Buyer: Multiplier Share and Stock Advisors Private Limited |
| Aug 2023 | Market trade | ₹24 Lakh | Seller: Dhwaja Shares & Securities Private Limited |
| Dec 2017 | Market trade | ₹38.8 Lakh | Buyer: Amit Jasani Financial Services Private Limited Seller: an individual |
Full deal history
All 18 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of TCM Limited
TCM Limited has 70 court cases on record: 33 filed by TCM, 24 filed against it, 13 where it is another party. 7 cases are pending and 63 are disposed. Status as checked between 21 Sep 2026 and 05 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 55 | 16 | 4 |
| District courts | 13 | 7 | 3 |
| Supreme Court | 1 | 1 | 0 |
| NCLT | 1 | 0 | 0 |
Cases on record (5 of 70)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Chennai, Tamil Nadu | Civil suit | Filed against the company by Amr Energy Resources Private Limited | Disposed |
| High Court of Kerala | Court case (AR) | Company is another party | Pending |
| District court, Ernakulam, Kerala | Court case (MA(Arb)) | Company is another party | Pending |
| High Court of Kerala | Writ petition | Filed by the company against an individual | Pending |
| District court, Salem, Tamil Nadu | Civil suit | Company is another party | Pending |
Full case history
All 70 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at TCM Limited
Employment history and EPFO contributions of people linked to TCM.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Group Structure of TCM Limited
TCM has 1 subsidiary company. This group structure data is as of FY 2020. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares Held |
|---|---|---|
| Ispark Learning Solutions Private Limited | U74999KL2020PTC061044 | - |
Showing major subsidiaries. Total: 1.
Recent Activity on TCM Limited
TCM Limited has 27 board changes on record since 2005: 18 appointments and 9 cessations. The latest: Bobby John was appointed as Director on 31 Dec 2022.
74 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for TCM Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by TCM Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of TCM Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of TCM Limited
TCM has 4 GST registrations: 2 active and 2 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 32AAACT6206A1Z4 | Kerala | Active | 01 Jul 2017 |
| 33AAACT6206A3Z0 | Tamil Nadu | Active | 12 Apr 2018 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of TCM Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Related news about TCM Limited
Frequently Asked Questions about TCM Limited
TCM is an active public limited company based in Kochi, Kerala, India. The company works in animal feeds, within the agriculture industry. It was incorporated on 20 April 1943 (83+ years old) and is registered under CIN L24299KL1943PLC001192. Listed on BSE: 524156.
TCM reported revenue of ₹19.74 Cr for FY 2025-26 (down 24.1% YoY) based on consolidated financials.
TCM has 8 current directors:
- Joseph Varghese - Managing Director
- Rani Jose - Director
- Jose Jacob - Director
- Gopalakrishnan Mahesh - Director
- George Varghese - Director
- Ramesh Babu - Director
- Sreenivasa Bhat Sadananda - Director
- Bobby John - Director
The GSTIN of TCM is 32AAACT6206A1Z4, registered in Kerala. The company has 4 GST registrations in all, of which 2 are active and 2 are cancelled or inactive. Other active GSTINs include 33AAACT6206A3Z0 (Tamil Nadu).
The CIN (Corporate Identification Number) of TCM is L24299KL1943PLC001192. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yes. TCM is listed on BSE with code 524156.
TCM has 70 court cases on record: 33 filed by the company and 24 filed against it. 7 are pending. Most are in the high courts.
TCM was incorporated on 20 April 1943, making it 83+ years old. It is registered with the Registrar of Companies, Ernakulam.
TCM has 18 deals on record (17 market trades, 1 rights issue); the latest was in May 2026.
The peers of TCM by revenue are Asomiya Mahila Poultry Producer Company Limited, Odisha State Medical Corporation Limited, Variety Vyapaar Pvt Ltd, Versatile Specialty Chemicals Limited, Gargi Chemicals Private Limited and 5 more, all in the Agriculture industry (Animal Feeds, Healthcare Equipment Retail and Distribution, Industrial Chemicals).
Bobby John was appointed as Director on 31 Dec 2022. Sreenivasa Bhat Sadananda was appointed as Director on 31 Dec 2022. Ramesh Babu was appointed as Director on 29 Sep 2022. TCM has 27 board changes on record in total.
